|
Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
#HashtagThis: Everything You Need to Know About Launching Your Gyn Onc Social Media Research Career On-Demand |
|
Enduring |
|
$0.00 |
|
Genetics Toolkit |
|
Enduring |
|
$0.00 |
|
Front Line Ovarian Cancer: Turning Up The Heat on Immunotherapy - 2020 Annual Meeting Webinar Series |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support: ICU and Perioperative Resources - Preparing for the ABOG Oral Exam (Pt. 3) |
|
Enduring |
|
$0.00 |
|
Treatment Related Cardiotoxicity: Review and Management Companion Card |
|
Enduring |
|
$0.00 |
|
Educating Your Trainee During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
Welcoming Spaces Pre-Course Survey |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
|
Molecular Target: Folate Receptor Alpha (FOLR1) |
|
Enduring |
|
$0.00 |
|
Navigating High Stakes Conversations in Gynecologic Oncology |
|
Enduring |
|
$0.00 |
|
Scientific Plenary VI: Hot Off The Press! Late Breaking Abstracts Part 2 |
|
Enduring |
|
$0.00 |
|
HER2 Testing in Gynecologic Cancers and Implications for Treatment |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Surgical Innovations in Gynecologic Cancers |
|
Enduring |
|
$0.00 |
|
SGO 2022 Annual Meeting ABOG Speaker: J. Nwando Olayiwola |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward